• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity

Medically reviewed by Carmen Pope, BPharm. Last updated on July 16, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, July 15, 2024 -- During the omicron era, hospital-onset severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remained associated with increased morbidity and mortality, according to a study published online July 16 in the Annals of Internal Medicine.

Michael Klompas, M.D., M.P.H., from Harvard Medical School and the Harvard Pilgrim Health Care Institute in Boston, and colleagues estimated the effect of nosocomial SARS-CoV-2 infection on hospitalized patients' outcomes during the pre-omicron and omicron eras. Hospital mortality and time to discharge were assessed as primary outcomes among adults testing positive for SARS-CoV-2 on or after hospital day 5, after negative SARS-CoV-2 test results on admission and on hospital day 3, and matched control participants.

Data were included for 274 cases of hospital-onset SARS-CoV-2 infection during the pre-omicron period and 1,037 cases during the omicron period (0.17 and 0.49 cases per 100 admissions, respectively). The researchers found that compared with those without, patients with hospital-onset SARS-CoV-2 were older and had more comorbid conditions. During the pre-omicron period, compared with control participants, hospital-onset SARS-CoV-2 infection was associated with an increased risk for intensive care unit (ICU) admission, an increased need for high-flow oxygen, longer time to discharge (median difference, 4.7 days), and higher mortality (risk ratio, 2.0). During the omicron period, an increased risk for ICU admission and increased time to discharge (median difference, 4.2 days) were still seen in association with hospital-onset SARS-CoV-2. The association with increased hospital mortality was still significant, although attenuated (risk ratio, 1.6).

"The frequency and persistent morbidity associated with hospital-onset SARS-CoV-2 infections in the omicron era suggest that hospitals should implement measures to prevent nosocomial SARS-CoV-2 infections," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.